Novalgina Acetaminophen Pain and Fever for Childrens

Description

The product associated with SPL Code 34089-3 does not have specific details regarding its chemical name, physical characteristics, or inactive ingredients available in the provided text. Further information may be required to furnish a comprehensive description.

Uses and Indications

This drug is indicated for the temporary reduction of fever. It also provides relief from minor aches and pains associated with various conditions, including the common cold, influenza, headache, sore throat, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer this product according to the following guidelines. It is imperative to adhere strictly to the recommended dosages, as this product does not provide comprehensive directions or warnings for adult use.

For optimal dosing, weight should be utilized when available; if weight is not applicable, age may be used as a substitute. The dosing intervals are as follows: the dose may be repeated every 4 hours while symptoms persist, with a maximum of 5 doses within a 24-hour period.

Administration should be performed using the enclosed dosing cup specifically designed for this product. The use of any other dosing device is not recommended.

Dosage by Weight and Age:

• For patients weighing under 24 lbs. (under 2 years), consultation with a physician is required prior to administration.

• For patients weighing 24-35 lbs. (2 - 3 years), the recommended dose is 5 mL.

• For patients weighing 36-47 lbs. (4 - 5 years), the recommended dose is 7.5 mL.

• For patients weighing 48-59 lbs. (6 - 10 years), the recommended dose is 10 mL.

• For patients weighing 60-71 lbs. (9 - 10 years), the recommended dose is 12.5 mL.

• For patients weighing 72-95 lbs. (11 years), the recommended dose is 15 mL.

It is essential to follow these guidelines to ensure safe and effective use of the product.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited. If there is uncertainty regarding the presence of acetaminophen in another medication, consultation with a healthcare professional is advised.

• This product should not be administered to children with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of severe liver damage if more than 5 doses are administered within a 24-hour period. This dosage limit applies to the total intake of acetaminophen from all sources, including other medications containing acetaminophen. Healthcare professionals should advise caregivers to strictly adhere to dosing guidelines to prevent potential hepatotoxicity.

Acetaminophen may also trigger severe skin reactions. Symptoms indicative of such reactions include skin reddening, blisters, and rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days, or if it is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a healthcare provider is recommended to rule out serious underlying conditions.

Before administering this product, healthcare professionals should inquire whether the child has a history of liver disease, as this may contraindicate use. Additionally, it is advisable to consult a doctor or pharmacist if the child is concurrently taking warfarin or other anticoagulants, due to potential interactions.

Patients should be instructed to discontinue use and seek medical advice if any of the following occur: worsening pain lasting more than 5 days, fever that worsens or persists beyond 3 days, the emergence of new symptoms, or the presence of redness or swelling. These signs may indicate a serious medical condition requiring further evaluation.

In the event of an overdose, immediate medical attention is crucial. Caregivers should contact a Poison Control Center (1-800-222-1222) without delay, as timely intervention is essential for both adults and children, even in the absence of overt symptoms.

Side Effects

Severe adverse reactions associated with this product include the potential for severe liver damage, particularly if more than 5 doses are taken within a 24-hour period. This warning is especially pertinent for patients using other medications that contain acetaminophen.

Patients may also experience severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of such a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Additionally, patients should be aware of the sore throat warning; if a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a healthcare provider should be consulted promptly.

Common adverse reactions may include worsening pain or fever that lasts beyond the recommended duration—pain lasting more than 5 days or fever lasting more than 3 days warrants medical consultation. New symptoms, as well as any redness or swelling, should also prompt a discussion with a healthcare professional, as these may indicate a serious condition.

Patients are advised against using this product in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. It is also contraindicated in patients with known allergies to acetaminophen or any inactive ingredients in the formulation.

Before using this product, it is recommended that patients consult a healthcare provider if they have liver disease or if they are taking blood-thinning medications such as warfarin.

In cases of overdose, immediate medical attention is critical. Patients or caregivers should contact a Poison Control Center or seek medical help without delay, even if no signs or symptoms are apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. The risk of acetaminophen overdose and associated hepatotoxicity is heightened when multiple sources of acetaminophen are used simultaneously. If there is uncertainty regarding the presence of acetaminophen in other medications, it is advisable to seek guidance from a healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Novalgina Acetaminophen Pain and Fever for Childrens (acetaminophen 160mg). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not exceed the recommended dosage, as this product does not provide complete warnings for adult use. Dosing should ideally be based on weight; if weight is not available, age may be used. Doses may be repeated every 4 hours while symptoms persist, with a maximum of 5 doses in a 24-hour period.

The recommended doses based on weight and age are as follows:

• For children under 24 lbs. (under 2 years), consult a doctor.

• For children weighing 24-35 lbs. (2-3 years), the dose is 5 mL.

• For children weighing 36-47 lbs. (4-5 years), the dose is 7.5 mL.

• For children weighing 48-59 lbs. (6-10 years), the dose is 10 mL.

• For children weighing 60-71 lbs. (9-10 years), the dose is 12.5 mL.

• For children weighing 72-95 lbs. (11 years), the dose is 15 mL.

Caution is advised due to the presence of acetaminophen, as severe liver damage may occur if more than 5 doses are taken within 24 hours. Additionally, acetaminophen may cause severe skin reactions, including skin reddening, blisters, or rash; if such symptoms occur, use should be discontinued, and medical assistance sought immediately.

Parents and caregivers should be aware of the sore throat warning: if a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a doctor should be consulted promptly. It is also important to seek medical advice before use if the child has liver disease or is taking the blood-thinning medication warfarin.

If pain worsens or lasts more than 5 days, fever worsens or lasts more than 3 days, new symptoms develop, or redness or swelling occurs, parents should stop use and consult a doctor, as these may indicate a serious condition. This product should be kept out of reach of children.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of Novalgina Acetaminophen during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, healthcare professionals should exercise caution when considering this medication for pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for the use of Novalgina Acetaminophen in pregnant women. Given the lack of information, it is advisable to weigh the potential benefits against any unknown risks when prescribing this medication to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of the drug in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if there is a concurrent liver disease. It is essential to evaluate the patient's overall health status, as reduced kidney function may necessitate careful consideration of dosing adjustments and monitoring strategies.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical to adhere to the maximum daily dosage of 5 doses within a 24-hour period, as exceeding this limit may lead to significant hepatic injury, particularly in individuals with compromised liver function.

Before administration, it is essential to consult a healthcare professional if the patient has a history of liver disease. This precaution is necessary to ensure the safe use of the product and to evaluate the potential need for dosage adjustments or additional monitoring based on the severity of the hepatic impairment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the severity of symptoms may vary based on the specific substance involved in the overdose. Therefore, a thorough assessment and monitoring of the patient are essential.

Management of an overdose may include supportive care and symptomatic treatment, tailored to the individual’s clinical presentation. Continuous evaluation and appropriate interventions should be initiated as necessary to mitigate potential complications.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients on the importance of seeking immediate medical assistance in the event of an overdose. Patients should be informed to contact a Poison Control Center at 1-800-222-1222 without delay.

It is crucial for patients to understand that quick medical attention is essential for both adults and children, even if they do not exhibit any noticeable signs or symptoms of overdose. Emphasizing this point can help ensure timely intervention and improve outcomes in such situations.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at a temperature range of 20-25°C (68-77°F) to ensure optimal stability and efficacy.

Healthcare professionals are advised to inspect the packaging prior to use; the product should not be utilized if the carton tape or bottle wrap is broken or missing, as this may compromise the integrity of the product. Proper handling and storage conditions are essential to maintain the quality of the product throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Novalgina Acetaminophen Pain and Fever for Childrens, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)